VEGFC and chondrosarcoma: Our study has identified that WISP-3 increased VEGF-C production and facilitated LEC lymphangiogenesis in human chondrosarcoma cells by inhibiting miR-196a-3p synthesis in the ERK, JNK, and p38 signaling pathways.